We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference

Product News   Feb 16, 2011

 
Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Sinovac COVID-19 Vaccine Collaboration Receives Approval for Phase III Trial

Product News

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines.

READ MORE

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Vaccine Against COVID-19 Advances to Late-stage Development

Product News

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE